Hepatoprotective Effects of Aqueous Extract of <i>Opilia celtidifolia</i> (Opiliaceae) Leaves against Ethanol-Induced Liver Damage in Rats

Amang, A. P.; Kodji, E.; Mezui, C.; Baane, M. P.; Siwe, G. T.; Kuissu, T. M.; Emakoua, J.; Tan, P. V.

doi:https://doi.org/10.1155/2020/6297475

Evidence-Based Complementary and Alternative Medicine

On this page

Abstract Introduction Materials and Methods Results Discussion Conclusions Data Availability Conflicts of Interest References Copyright Related Articles

Research Article | Open Access

Volume 2020 | Article ID 6297475 | https://doi.org/10.1155/2020/6297475

Hepatoprotective Effects of Aqueous Extract of Opilia celtidifolia (Opiliaceae) Leaves against Ethanol-Induced Liver Damage in Rats

A. P. Amang,¹E. Kodji,¹C. Mezui,²M. P. Baane,³G. T. Siwe,⁴T. M. Kuissu,⁵J. Emakoua,⁴and P. V. Tan⁴

Academic Editor: Muhammad Jahangir Hossen

Received17 Jan 2020

Revised28 Sept 2020

Accepted29 Sept 2020

Published24 Oct 2020

Abstract

Objective. Opilia celtidifolia is a plant used in Cameroonian ethnomedicine to cure jaundice. The aim of this study was to evaluate the hepatoprotective activity of O. celtidifolia leaves aqueous extract in rats subjected to ethanol-induced liver damage. Material and Methods. 36 rats including 18 males and 18 females were divided into 6 groups of 3 males and 3 females each, namely, 3 control groups (normal, negative, positive) and 3 test groups. The normal and negative control groups were given distilled water (5 ml/kg), the positive control group received silymarin (100 mg/kg), and the test groups were given O. celtidifolia extract at the doses of 100, 200, and 400 mg/kg. All groups, except the normal control, received concomitantly and daily 40% ethanol (4 g/kg) for 3 weeks to induce hepatotoxicity. Biochemical parameters such as alanine aminotransferase (ALT), aspartate aminotransferase (AST), alkaline phosphatase (ALP), bilirubin, and lipid profile (total cholesterol, HDL, LDL, and triglycerides) were evaluated. Histological sections of the liver, kidneys, and lungs were examined. Qualitative and quantitative phytochemical analysis of the extract were carried out. Results. The groups treated with the extract at the doses of 200 and 400 mg/kg showed a significant decrease () of transaminases (ALT and AST), ALP, and bilirubin compared with the negative control. These results were confirmed by observation of histological sections of the liver that confirmed protective action of extract against ethanol-induced hepatocellular injury. Conclusion. O. celtidifolia possesses hepatoprotective properties that could be related to its high content of tannins and saponins in the leaves aqueous extract.

1. Introduction

The liver is one of the animal body organs that ensures the detoxification and elimination of substances found in the blood [1]. When blood levels of alcohol exceed the detoxifying capacity of the liver, liver cells are attacked causing hepatitis (inflammation of liver cells). Liver damage can also be caused by viruses or toxic substances from bioactivation of metabolites of drugs [2].

According to the World Health Organization [3] (WHO), in 2012, 325 million people around the world were suffering from viral hepatitis, with 95% of them being unaware of their infection, and 1.4 million hepatitis-related deaths occur each year. Hepatitis is the 10^th leading cause of death in the world, with Africa being the continent with the highest prevalence (6.15%). The prevalence in Cameroon is 11%, ranking the latter among the most affected countries in Africa after Egypt (18%) and Rwanda (14%) [3]. According to the Ministry of Public Health statistics in 2016, 200,000 people were affected by viral hepatitis in Cameroon. It is also established that toxic substances cause about 10% of acute liver failures [4]. In the case of alcoholic hepatitis, 13.5% of people worldwide who regularly drink alcohol are suffering from hepatitis. Consumption of alcohol above 25 g/day increases the cirrhosis risk by 1.5 to 3.6% [5]. The complications of alcoholic hepatitis depend on the frequency and duration of consumption as well as the dose of alcohol ingested [6].

The treatment of viral hepatitis by modern medicine consists of taking interferons: Lamivudine, Tenofovir, Adefovir, and Ribavirin [7]. Nonviral hepatitis is treated by the suppression of the cause, accompanied by the taking of hepatoprotective agents such as Simepar or Silybon [8]. Due to inaccessibility of treatment and the numerous drug side effects, people in developing countries are increasingly embracing the use of medicinal plants to treat these pathologies.

Opilia celtidifolia belongs to the Opiliaceae family. It is found in Mali, Senegal, Nigeria, and the Far North Region of Cameroon [9]. The phytochemical screening of the leaves aqueous extract shows phlobatannins, alkaloids, terpenoids, and anthraquinones [10]. It is one of the plants commonly used by the population of the Far North Region of Cameroon for its many therapeutic virtues including the treatment of jaundice, chest, and abdominal pains [9]. Ethnobotanical studies show that the leaves of O. celtidifolia are used for the traditional treatment of hepatitis in Benin [11] and jaundice in Mali [12], and according to the work of Traoré et al., the decoction leaves of Opilia celtidifolia are taken to treat hepatitis [13]. Hence, the objective of this study was to evaluate the hepatoprotective activity of O. celtidifolia leaves aqueous extract in rats.

2. Materials and Methods

2.1. Plant Material

Opilia celtidifolia leaves were harvested in July 2018, around Mokolo, Mayo-Tsanaga Division, Far North Region of Cameroon (10°44′32.78″N 13°48′8.17″E). The sample was then authenticated at the Herbarium of the Garoua Wildlife School by Mr. Vounserbo through comparison with the existing voucher specimen recorded under N^o HEFG/1962. These leaves were dried in the shade at room temperature, then ground in a clean mortar, and sieved. The fine powder obtained was used for the preparation of the aqueous extract.

2.2. Animal Material

Thirty-six albino Wistar rats of both sexes, 7 to 8 weeks old, with an average body weight of 100 ± 20 g were obtained from the Animal House of the Laboratory of Biological Sciences of the University of Ngaoundere. These animals had not been subjected to any previous experimentation. They were acclimatized in the Laboratory of Animal Physiology and Pharmacology of the University of Maroua for two weeks. The rats were subjected to natural day/night cycle at room temperature and fed with a standard diet, with free access to tap water. Prior authorization for the use of laboratory animals in this study was obtained from the Cameroon National Ethics Committee (Registration number FWA-IRB00001954). The use, handling, and care of animals were done with adherence to the European Convention for the Protection of Vertebrate Animals used for experimental and other purposes (ETS-123), with particular attention to Part III, articles 7, 8, and 9 [19].

2.3. Preparation of O. celtidifolia Leaf Aqueous Extract

The decoction of O. celtidifolia was prepared by boiling 300 g of O. celtidifolia powder in 3 liters of distilled water for 15 minutes. The mixture was allowed to cool and filtered using Whatman filter paper №3. The filtrate was evaporated in a ventilated oven at 50°C for 24 hours. The dry extract obtained weighed 25.9 g, representing an extraction yield of 8.63%. This extract was stored at 4°C in a refrigerator throughout the experiment [15].

2.4. Qualitative and Quantitative Phytochemical Tests

The protocol described by Harborne [16] was used for qualitative phytochemical tests of the aqueous extract of O. celtidifolia leaves in order to detect the presence or absence of secondary metabolites classes such as flavonoids, phenols, tannins, proteins, saponins, and coumarins.

The saponins and tannins contents were determined using the method described by Brunner [17, 18]. The contents of saponins and tannins were determined from the linear regression equation curve plotted with the standard solutions, galactose and catechin, respectively.

2.5. Animal Distribution and Treatment

After a two-week acclimatization period, the 36 rats were randomized and divided into 6 groups of 6 rats including three males and three females. Males and females of the same group were kept separately in cages as follows: group I: normal control, which received distilled water (5 ml/kg/day) for 21 days; group II: negative control treated with ethanol (4 g/kg/day) given concomitantly with distilled water (5 ml/kg/day) for 21 days; group III: positive control treated with ethanol (4 g/kg/day) and concomitantly treated daily with Simepar (oral route) at the dose of 100 mg/kg for 21 days; groups IV, V, and VI: treated, respectively, with the extract of O. celtidifolia at the doses of 100, 200, and 400 mg/kg/day given concomitantly with 40% ethanol (4 g/kg/day) for 21 days. The ethanol was used to induce hepatotoxicity [19].

2.6. Animal Euthanasia and Biochemical Assays

The next day following the end of the treatment period, all the rats were sacrificed by decapitation, and the blood was collected in dry tubes and centrifuged at 4000 rpm for 15 minutes at 4°C. The serum obtained was stored at −20°C for the measurement of biochemical parameters. The transaminases (ALT and AST) were assayed by the method described by Reitman and Frankel [20] using Giesse Diagnostics AST/GOTSL Kits and Atlas Medical GOT Kit. Serum alkaline phosphatase (ALP) concentration was determined according to the method described by Otto et al. [21] using Q-SLAP Alkaline Phosphatase (DEA) Kit, Biotec Diagnostics Ltd., UK.

Enzyme linked immunosorbent assay kits were used to determine enzyme profiles. Bilirubin was determined by the colorimetric method described by Doumas et al. [22] using Biotec Diagnostics Ltd. Kit, UK, and Direct DMSO Kits. Total cholesterol was determined according to the method described by Allain et al. [23] using Hospitex Diagnostics SARL cholesterol kits. HDL cholesterol levels were determined according to the method of Lopes-Virella et al. [24] using Q-SLAP HDL Cholesterol Kit, Biotec Diagnostics Ltd., UK. The concentration of LDL cholesterol in the samples was determined by the equation of Fridewald et al. [25]. Triglyceride concentrations were determined according to the method described by Bucolo and David [26] using Giesse Diagnostics SL, GPO-POD Kits. The colorimetric method described by Gornall et al. [27] was used to assay total protein.

2.7. Histopathological Analysis

Liver, kidney, and lung tissue samples were collected, weighed, rinsed in saline (0.9% NaCl), and stored in 10% buffered formaldehyde solution for histopathological examination according to the methods described by Rhiouani et al. [28] and Lienou et al. [29].

2.8. Statistical Analysis

The data were analyzed using Analysis of Variances (ANOVA), followed by the Bonferroni comparison test as a posttest using GraphPad Prism software, version 5.03, and the results were expressed as mean ± standard error on mean (SEM).

3. Results

3.1. Phytochemical Analysis of O. celtidifolia

Qualitative phytochemical screening of the aqueous extract of O. celtidifolia leaves revealed the presence of some classes of bioactive compounds such as tannins and saponins (Table 1).

The quantification of bioactive compound revealed that 100 g of dry extract contains 6.48 Eqg Galac/100 g of saponin and 9.41 Eqg Catech/100 g of tannin (Table 2).

3.2. Effects of O. celtidifolia on Body Weight

Table 3 shows the changes in body weight (g/animal/week) of rats. There was no significant difference in body weight of rats treated with O. celtidifolia extract compared to the negative control.

3.3. Effects of O. celtidifolia on Some Serum Parameters of Liver Function

Table 4 shows that the daily administration of ethanol (4 g/kg) for 21 days induced a significant increase of transaminases levels (ALT and AST), alkaline phosphatase, and bilirubin of the negative control group compared to the normal controls. Treatment with O. celtidifolia extract resulted in a decrease in serum levels of these parameters in the different groups. However, the decrease in ALT was significant () only at the doses of 100 and 200 mg/kg. As for AST at 400 mg/kg, the extract showed slight tendency to raise transaminase levels compared to the dose of 200 mg/kg (ALT and AST). The extract induced a significant decrease () in ALP and bilirubin only at the dose of 100 mg/kg in rats compared to the negative controls.

3.4. Effects of O. celtidifolia on the Lipid Profile and Total Protein

Table 5 shows the results of the lipid profiles and total protein levels of the different groups. There was a significant decrease () of total cholesterol in groups treated with extract at the dose of 400 mg/kg. A significant decrease in total protein was observed in the negative control group () compared to the normal control. However, protein values remained close to the normal control levels in the groups treated with extract.

3.5. Effects of O. celtidifolia on Histology

Microphotographs of the liver of normal male and female rats showed normal hepatic parenchyma architecture with hepatocytes arranged in cobblestones around the centrilobular vein (Figures 1(a)A and 2(a)A). Negative control groups showed liver alterations characterized by hepatic cytolysis in rats (Figure 1(a)B and 2(a)B). Rats treated with the extract at the doses of 200 (Figures 1(a)D and 2(a)D) and 400 mg/kg (Figures 1(a)E and 2(a)E) and Simepar (Figures 1(a)F and 2(a)F) showed an improvement in liver structures similar to the normal controls rats.

(a)

(b)

(c)

(a)

(b)

(c)

Histology of renal tissues in normal rats showed a normal architecture of glomeruli, urinary spaces, and proximal and distal convoluted tubules (Figures 1(b)A and 2(b)A). Negative control groups showed renal cell changes characterized by mesangial expansions (Figures 1(b)B and 2(b)B) compared to normal controls. Rats treated with the extract at the doses of 100 (Figures 1(b)C and 2(b)C) and 400 mg/kg (Figures 1(b)E and 2(b)E) and Simepar (Figures 1(b)F and 2(b)F) showed an improvement in kidney architecture structures approximating that of normal control in both sexes.

Lung microphotographs of normal rats showed normal architecture of bronchioles, arterioles, and alveolar sacs (Figures 1(c)A and 2(c)A). Negative control group (Figures 1(c)B and 1(c)B) showed inflammatory granulomas compared to normal control. These alterations were improved in groups treated with the O. celtidifolia leaf aqueous extract in males, particularly at the doses of 200 and 400 mg/kg in females (Figures 1(c)D and 1(c)E, respectively). The rats treated with Simepar (Figures 1(c)F and 2(c)F) showed an improvement in lung histology similar to normal controls.

4. Discussion

The liver is subject to xenobiotic-induced injury because of its central role in the metabolism of xenobiotics, its portal location in the circulation, and its anatomical and physiological structure. Daily administration of ethanol (40%) at a dose of 4 g/kg for 21 days to rats induced a significant increase () of ALT and AST in the negative control groups compared to normal control rats. Increased serum levels of ALT and AST are clinical signs of hepatic injury resulting from loss of hepatocyte membrane integrity, with release of these enzymes into the serum [30]. Thus, serum levels of ALT and AST activity can be used to indirectly evaluate the integrity of liver tissue after exposure to certain toxic agents [31]. Therefore, AST appears in higher concentrations in a number of tissues (liver, kidneys, heart, and pancreas) and is released slowly in comparison to ALT. However, since ALT is localized primarily in the cytosol of hepatocytes, this enzyme is considered a more sensitive marker of liver inflammation or damage than AST and within limits can provide a quantitative assessment of the degree of damage sustained by the liver [32]. The significant decrease () of ALT and AST levels observed in rats treated with the extract at 200 and 400 mg/kg, compared to the negative control, suggests inhibition of hepatocellular injury by the extract. These results are similar to those of Ngueguim et al. [33], who showed that daily administration of the aqueous extract of Dichrocephala integrifolia to rats followed by ingestion of ethanol for 14 days induced a significant decrease in transaminases. It was suggested that the extract either protected cell membranes or counteracted the deleterious effects of ethanol via cytochrome P450 inhibition or stimulation of the gene responsible for hepatocyte regeneration; this is because of the presence of classes of bioactive compounds in the extract such as tannins and saponins revealed by qualitative and quantitative phytochemical analysis.

In cases of hepatic toxicity, serum bilirubin levels rise due to insufficient absorption of unconjugated bilirubin by the liver. This explains the high bilirubin levels in the negative controls rats compared to the normal controls. This biliary constituent reaches the plasma through tight junctions between the biliary canaliculi and sinusoids [34]. The groups treated with O. celtidifolia extract showed a significant () decrease of bilirubin levels at the doses of 100, 200, and 400 mg/kg. These results are similar to those of Dahiru and Obidoa [35], who demonstrated that daily administration of Ziziphus mauritiana bark aqueous extract for 6 weeks resulted in bilirubin decrease following induction of hepatocellular carcinoma with ethanol. This decrease may be linked to the presence of saponins in the extract capable of protecting the membranes of hepatocytes [36]. The significant decrease () of alkaline phosphatase (ALP) observed in the rats treated at 400 mg/kg could be a clinical indication of the inhibition of cholestasis by the extract. These results corroborate those obtained by Dahiru and Obidoa [35] who demonstrated that daily administration of Ziziphus mauritiana bark aqueous extract for 6 weeks resulted in a decrease of ALP and bilirubin in the serum of the rats following induction of hepatotoxicity with ethanol. They suggested that the decline in these parameters could be due to the presence of phytoconstituents such as tannins capable of counteracting the toxic effects of alcohol on the hepatocyte membranes.

Ethanol consumption increases lipogenesis, leading to excessive synthesis of fatty acids and triglycerides, which contributes to the accumulation of fat in the liver [36]. It also inhibits the activity of lipases involved in the transformation of lipoproteins and triglycerides [37]. Inhibition of these enzymes induces changes in the lipid profile (steatosis). Evaluation of these parameters provides information on the adverse effects of ethanol on lipoprotein and triglyceride transformation enzymes [33].

In this study, only the dose of 400 mg/kg of the extract showed a significant decrease of total cholesterol and triglyceride in rats compared to the negative control. HDL and LDL cholesterol remained close to normal values although extract doses of 100–200 mg/kg tended to reduce their values. Proinflammatory cytokines, particularly TNF-α, are involved in Kupffer cell activation, hepatic necrosis, endothelial damage, and tissue recruitment of neutrophils in alcoholic liver disease [36]. These results are in line with those obtained by Ngueguim et al. [33], who demonstrated that daily administration of Dichrocephala integrifolia leaves aqueous extract to rats followed by ethanol intoxication for 14 days lowered cholesterol and triglyceride levels. They suggested that these effects would be due to the presence of classes of bioactive compounds such as tannins in the extract capable of stabilizing and protecting the integrity of the hepatocyte membrane.

Several proteins synthesized in the liver are found in the blood [38]. Administration of extract restored the serum total protein levels around the normal values after the decrease observed in negative controls. These results could be due to the presence of compounds such as tannins that are able to stimulate genes responsible for protein biosynthesis.

Macroscopic observation of the main organs revealed no abnormalities. Histopathological studies of the liver showed that the architecture of the liver was intact in normal controls; hepatocytes, sinusoids, central veins, and portal veins occur within the normal range in both sexes. Negative control groups showed partial loss of hepatic architecture. The centrilobular vein appeared to be slightly dilated, and the hepatocytes showed degeneration between the lobules. Sinusoids were within normal limits, and there was moderate lymphocyte infiltration in response to inflammation in the periportal region, with overflows in adjacent hepatocytes associated with hemorrhage. These different manifestations are due to the deleterious effects of ethanol, which, during its metabolism, releases acetaldehyde which is potentially toxic to the membrane of hepatocytes [39]. In the group treated with silymarin, the architecture of the liver was preserved; several hepatocytes showed signs of regeneration and slight lymphocyte infiltration. This confirms the hepatoprotective effects of silymarin against the deleterious effects of ethanol. The group treated with the aqueous leaf extract of O. celtidifolia at the dose of 200 mg/kg showed no lymphocyte infiltration in male and female rats with a liver architecture close to normal. This suggests that O. celtidifolia at this dose could significantly protect hepatocytes from the toxic effects of ethanol. These effects are illustrated by increased hepatocyte regeneration and moderate degeneration, which might be related to the fact that the extract contains bioactive compounds whose hepatoprotective effects are well known.

The histological study of lung and kidney tissues in male and female rats revealed that the negative control groups showed signs of lung and renal cell damage characterized by the formation of inflammatory granulomas and mesangial expansions in both sexes compared to normal controls. These effects are thought to be due to the deleterious effects of excessive ethanol on lung and kidney tissues. The groups treated with extract at the doses of 200 and 400 mg/kg as well as animals treated with silymarin showed an improvement in lung and renal structures close to those of normal controls, suggesting protection of these tissues against the deleterious effects of ethanol by the plant extract.

5. Conclusions

This study shows that O. celtidifolia extract decreased serum levels of (ALT and AST) transaminases, alkaline phosphatase, bilirubin, triglyceride, and total cholesterol. The extract also prevented histopathological changes in the liver, kidneys, and lungs due to the toxicity of ethanol. The hepatoprotective effects observed could be due to the presence of tannins and saponins.

Data Availability

The data used to support the findings of this study are available from the corresponding author upon request.

Conflicts of Interest

The authors declare that they have no conflicts of interest regarding the publication of this paper.

References

P. A. Just, Étude du rôle de LKB1 dans le foie, Université Paris-Sud, Orsay, France, 2014, Thèse de Doctorat.
R. L. Drake, F. Duparc, J. Duparc, A. H. G. Mitchell, A. W. Vogl, and J. Scott, Gray’s Anatomie pour les étudiants, Édition Elsevier Health Sciences, Amsterdam, Netherlands, 2015.
Organisation Mondiale de la Santé, Prévention et lutte contre l’hépatite virale : Cadre pour l’action mondiale, Organisation Mondiale de la Santé, Genève, Switzerland, 2012.
B. Mégarbane, N. Deye, and F. Baud, “Foie toxique : mécanismes lésionnels et thérapeutiques pharmacologiques spécifiques,” Réanimation, vol. 16, no. 7-8, pp. 632–642, 2007.
View at: Publisher Site | Google Scholar
G. Corrao, A. Zambon, P. Torchio, S. Aricò, C. La Vecchia, and F. Di Orio, “Attributable risk for symptomatic liver cirrhosis in Italy,” Journal of Hepatology, vol. 28, no. 4, pp. 608–614, 1998.
View at: Publisher Site | Google Scholar
K. Breitkopf, L. E. Nagy, J. I. Beier, S. Mueller, H. Weng, and S. Dooley, “Current experimental perspectives on the clinical progression of alcoholic liver disease,” Alcoholism: Clinical and Experimental Research, vol. 33, no. 10, pp. 1647–1655, 2009.
View at: Publisher Site | Google Scholar
D. Sène, D. Saadoun, N. Limal, J.-C. Piette, and P. Cacoub, “Actualités des manifestations extrahépatiques associées au virus de l’hépatite C,” La Revue de Médecine Interne, vol. 28, no. 6, pp. 388–393, 2007.
View at: Publisher Site | Google Scholar
J. C. Trinchet, T. Coste, V. G. Levy et al., “Traitement de l’hépatite alcolique par la silymarine, une étude comparative en double insu chez 116 malades,” Gastroentérologie Clinique et Biologique, vol. 13, no. 2, pp. 1220–1224, 1989.
View at: Google Scholar
A. Togola, Series of Dissertations Submitted to the Faculty of Mathematics and Natural Sciences, University of Oslo, Oslo, Norway, 2008, Theiss of Doctorate.
M. S. Owolabi, A. A. Omowonuola, A. Lawal, Oladipupo et al., “Phytochemical and bioactivity screening of six Nigerian medicinal plants,” Journal of Pharmacognosy and Phytochemistry, vol. 6, no. 6, pp. 1430–1437, 2017.
View at: Google Scholar
F. Guinnin, T. Sacramento, A. Sezan, and J. Ategbo, “Etude Ethnobotanique des plantes médicinales utilisées dans le traitement traditionnel des hépatites virales B et C dans quelques départements du Bénin,” International Journal of Biological and Chemical Sciences, vol. 9, no. 3, pp. 1354–1366, 2015.
View at: Publisher Site | Google Scholar
S. Makan, Étude de l’activité appétissante du décocté de feuilles de Opilia celtidifolia Guill. Et Perr (Opiliaceae) chez les rats, Université des Sciences, des Techniques et des Technologies de Bamako, Bamako, Mali, 2012, Thèse de Doctorat en Pharmacie.
T. K. Traoré, T. Andre, O. Noufou, S. N. Ernest, N. d. J. Yhi-pene, and G. I. Pierre, “Ethnopharmacological plants used to treat hepatitis and their anti-oxidant activity of district of Bobo-Dioulasso (Burkina Faso),” International Journal of Pharmacological Research, vol. 8, no. 3, pp. 15–23, 2018.
View at: Publisher Site | Google Scholar
Council of Europe, “European convention for the protection of vertebrate animals used for experimental and other scientific purposes,” European Treaty Series, vol. 123, pp. 4–6, 1986.
View at: Google Scholar
L. P. Aimee, L. Normilando, M. L. Raizel, L. Jeffrey, J. M. Patricia et al., “Hepatoprotective effect of crude aqueous leaf extract of fig tree, Ficus benjamina, on ethanol-induced liver damage in mice,” International Journal of Scientific & Technology Research, vol. 6, no. 6, pp. 119–121, 2017.
View at: Google Scholar
J. B. Harborne, Textbook of Phytochemical Methods. A Guide to Modern Techniques of Plant Analysis, Chapman & Hall, London, UK, 5th edition, 1998.
J. H. Brunner, “Direct spectrophotometric determination of Saponine,” Analytical Chemistry, vol. 34, pp. 1314–1326, 1984.
View at: Google Scholar
J. L. Owades, G. Rubin, and M. W. Brenner, “Food tannins measurement, determination of food tannins by ultraviolet spectrophotometry,” Journal of Agricultural and Food Chemistry, vol. 6, no. 1, pp. 44–46, 1958.
View at: Publisher Site | Google Scholar
S. Sadhana, D. A. Poornima, B. M. Vinam et al., “Hepatoprotective activity of Murraya koenigii against ethanol induced liver toxicity model in experimental animals,” International Journal of Pharmacology and Biosciences, vol. 3, no. 1, pp. 430–438, 2012.
View at: Google Scholar
S. Reitman and S. Frankel, “A colorimetric determination of serum glutamic oxalo-acetic and glutamic pyruvic transaminase,” American Journal of Clinical Pathology, vol. 28, no. 16, pp. 59–63, 1957.
View at: Publisher Site | Google Scholar
A. Otto, H. Oliver, and M. Jane, “A method for rapid determination of Alkaline Phosphatase with five cubic millimeters of serum,” Journal of Biological Chemistry, vol. 164, no. 3, pp. 321–329, 1946.
View at: Google Scholar
B. T. Doumas, P. P. Kwok-Cheung, B. W. Perry et al., “Candidate reference method for determination of total Bilirubin in serum: development and validation,” Clinical Chemistry, vol. 31, no. 11, pp. 1779–1789, 1985.
View at: Publisher Site | Google Scholar
C. C. Allain, L. S. Poon, C. S. G. Chan, W. Richmond, and P. C. Fu, “Enzymatic determination of total serum cholesterol,” Clinical Chemistry, vol. 20, no. 4, pp. 470–475, 1974.
View at: Publisher Site | Google Scholar
M. F. Lopes-Virella, P. Stone, S. Ellis, and J. A. Colwell, “Cholesterol determination in high-density lipoproteins separated by three different methods,” Clinical Chemistry, vol. 23, no. 5, pp. 882–884, 1977.
View at: Publisher Site | Google Scholar
W. T. Fridewald, R. I. Levy, and D. S. Fredrickson, “Estimation of the concentration of low-density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge,” Journal of Biological Chemistry, vol. 18, no. 6, pp. 499–502, 1972.
View at: Google Scholar
G. Bucolo and H. David, “Quantitative determination of serum triglycerides by the use of enzymes,” Clinical Chemistry, vol. 19, no. 5, pp. 476–482, 1973.
View at: Publisher Site | Google Scholar
A. G. Gornall, C. J. Bardawill, and M. M. David, “Determination of serum proteins by means of biuret reactions,” Journal of Biological Chemistry, vol. 17, no. 7, pp. 751–766, 1949.
View at: Google Scholar
H. Rhiouani, J. El-hilaly, Z. H. Israili, and B. Lyoussi, “Acute and subchronic toxicity of an aqueous extract of the leaves of Hernia riaglabra in rodents,” Journal of Ethnopharmacology, vol. 118, no. 6, pp. 378–386, 2008.
View at: Publisher Site | Google Scholar
T. C. Lienou, F. X. Etoa, B. Nkegoum, C. A. Pieme, and D. P. D. Dzeufiet, “Acute and subacute toxicity of Aspilia africana leaves,” African Journal Traditional Complementary and Alternative Medicine, vol. 4, no. 2, pp. 127–134, 2007.
View at: Google Scholar
H. Olson, G. Betton, D. Robinson, K. Thomas, A. Monro, and G. Kolaja, “Concordance of toxicity of pharmaceuticals in humans and in animals,” Regulatory Toxicology and Pharmacology, vol. 32, no. 6, pp. 56–67, 2000.
View at: Publisher Site | Google Scholar
J. Fulcrand, A. Lerooy, J. Giraud et al., “Cytolyse hépatique sous dabigatran étexilate chez un sujet âgé,” Therapies, vol. 68, no. 5, pp. 332–334, 2013.
View at: Publisher Site | Google Scholar
F. Al-Hashem, “Camel’s milk protects against aluminum chloride-induced toxicity in the liver and kidney of white albino rats,” American Journal of Biochemistry and Biotechnology, vol. 5, no. 3, pp. 98–109, 2009.
View at: Publisher Site | Google Scholar
T. F. Ngueguim, A. Mbatchou, J. H. Donfack, D. D. P. Dzeufie, and K. R. Gounoue, “Dichrocephala integrifolia (Linn. f.) O. kuntze (Asteraceae) leaves aqueous extract prevents ethanol-induced liver damage in rats,” Pharmacologia, vol. 7, no. 6-7, pp. 337–343, 2016.
View at: Google Scholar
S. Berthélémy, “Le bilan hépatique,” Actualités Pharmaceutiques, vol. 54, no. 544, pp. 59–61, 2015.
View at: Publisher Site | Google Scholar
D. Dahiru and O. Obidoa, “Evaluation of the antioxidant effect of Zizizphus moritiana lam. leaf extract against chronic ethanol-induced hepatototxity in rat liver,” African Journal of Traditional Complementary and Alternative Medicine, vol. 5, no. 1, pp. 39–45, 2008.
View at: Publisher Site | Google Scholar
M. You and D. W. Crabb, “Recent advances in alcoholic liver disease II. Minireview: molecular mechanisms of alcoholic fatty liver,” American Journal of Physiology, Gastrointestinal and Liver Physiology, vol. 287, 2004.
View at: Publisher Site | Google Scholar
O. B. F. Aboubakar, N. M. T. Bella, L. T. E. Ngo, D. C. Bilanda, and T. Dimo, “Antihypertensive activity of Jateo rhizamacrantha (Menispermaceae) aqueous extract on ethanol-induced hypertension in wistar,” International Journal of Pharmacology Pharmacognosy Sciences, vol. 4, no. 3, pp. 293–298, 2012.
View at: Google Scholar
C. F. Berr, S. Clavel-Chapelon, J. L. D. Dally, and F. Fumeron, “Alcool : effets sur la santé,” nstitut National de la Santé et de la Recherche Médicale, vol. 34, I, 2001.
View at: Google Scholar
M. Hiral, P. Vishnu, and P. Komal, “Hepatoprotective activity of Aeglemarrmelos against ethanol induced hepatotoxicity in rats,” Asian Journal of Pharmaceutical and Clinical Research, vol. 5, no. 4, pp. 164–167, 2012.
View at: Google Scholar

Copyright

Copyright © 2020 A. P. Amang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

PDF Download Citation

Download other formats

Order printed copies

Views

1587

Downloads

910

Citations